Skip to main content

Neurokinin-1 Receptor

  • Reference work entry
  • First Online:
Book cover Encyclopedia of Signaling Molecules

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 4,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 4,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Akazawa T, Kwatra SG, Goldsmith LE, Richardson MD, Cox EA, Sampson JH, Kwatra MM. A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas. J Neurochem. 2009;109:1079–86.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Barrett JS, Spitsin S, Moorthy G, Barrett K, Baker K, Lackner A, Tulic F, Winters A, Evans DL, Douglas SD. Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV. J Transl Med. 2016;14:148.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Berger M, Neth O, Ilmer M, Garnier A, Salinas-Martín MV, de Agustín Asencio JC, von Schweinitz D, Kappler R, Muñoz M. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be inhibited by aprepitant in vitro and in vivo. J Hepatol. 2014;60:985–94.

    Article  CAS  PubMed  Google Scholar 

  • DeFea KA, Vaughn ZD, O’Bryan EM, Nishijima D, Déry O, Bunnett NW. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta-arrestin-dependent scaffolding complex. Proc Natl Acad Sci U S A. 2000;97:11086–91.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Douglas SD, Leeman SE. Neurokinin-1 receptor: functional significance in the immune system in reference to selected infections and inflammation. Ann N Y Acad Sci. 2010;1217:83–95.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Esteban F, Muñoz M, González-Moles MA, Rosso M. A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogene activation or DNA damage. Cancer Metastasis Rev. 2006;25:137–45.

    Article  CAS  PubMed  Google Scholar 

  • Fong TM, Anderson SA, Yu H, Huang RR, Strader CD. Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. Mol Pharmacol. 1992;41:24–30.

    CAS  PubMed  Google Scholar 

  • Garcia M, Sakamoto K, Shigekawa M, Nakanishi S, Ito S. Multiple mechanisms of arachidonic acid release in Chinese hamster ovary cells transfected with cDNA of substance P receptor. Biochem Pharmacol. 1994;48:1735–41.

    Article  CAS  PubMed  Google Scholar 

  • García-Recio S, Gascón P. Biological and pharmacological aspects of the NK1-receptor. Biomed Res Int. 2015;2015:495704.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Gerard NP, Garraway LA, Eddy Jr RL, Shows TB, Iijima H, Paquet JL, Gerard C. Human substance P receptor (NK-1): organization of the gene, chromosome localization, and functional expression of cDNA clones. Biochemistry. 1991;30:10640–6.

    Article  CAS  PubMed  Google Scholar 

  • Gillespie E, Leeman SE, Watts LA, Coukos JA, O’Brien MJ, Cerda SR, Farraye FA, Stucchi AF, Becker JM. Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer. Proc Natl Acad Sci U S A. 2011;108:17420–5.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hesketh PJ, Gralla RJ, Webb RT, Ueno W, DelPrete S, Bachinsky ME, Dirlam NL, Stack CB, Silberman SL. Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis. J Clin Oncol. 1999;17:338–43.

    Article  CAS  PubMed  Google Scholar 

  • Ho WZ, Kaufman D, Uvaydova M, Douglas SD. Substance P augments interleukin-10 and tumor necrosis factor-alpha release by human cord blood monocytes and macrophages. J Neuroimmunol. 1996;71:73–80.

    Article  CAS  PubMed  Google Scholar 

  • Hopkins B, Powell SJ, Danks P, Briggs I, Graham A. Isolation and characterisation of the human lung NK-1 receptor cDNA. Biochem Biophys Res Commun. 1991;180:1110–7.

    Article  CAS  PubMed  Google Scholar 

  • Kage R, Leeman SE, Krause JE, Costello CE, Boyd ND. Identification of methionine as the site of covalent attachment of a p-benzoyl-phenylalanine-containing analogue of substance P on the substance P (NK-1) receptor. J Biol Chem. 1996;271:25797–800.

    Article  CAS  PubMed  Google Scholar 

  • Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NM. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 1998;281:1640–5.

    Article  CAS  PubMed  Google Scholar 

  • Lang K, Drell TL, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS, Entschladen F. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer. 2004;112:231–8.

    Article  CAS  PubMed  Google Scholar 

  • Laniyonu A, Sliwinski-Lis E, Fleming N. Different tachykinin receptor subtypes are coupled to the phosphoinositide or cyclic AMP signal transduction pathways in rat submandibular cells. FEBS Lett. 1988;240:186–90.

    Article  CAS  PubMed  Google Scholar 

  • Lee M, Choi S, Halldén G, Yo SJ, Schichnes D, Aponte GW. P2Y5 is a Gαi, Gα12/13 G protein-coupled receptor activated by lysophosphatidic acid that reduces intestinal cell adhesión. Am J Physiol Gastrointest Liver Physiol. 2009;297:G641–54.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lieb K, Fiebich BL, Berger M, Bauer J, Schulze-Osthoff K. The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol. 1997;159:4952–8.

    CAS  PubMed  Google Scholar 

  • Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 1988;241:1218–21.

    Article  CAS  PubMed  Google Scholar 

  • Luo W, Sharif TR, Sharif M. Substance P-induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signaling pathway. Cancer Res. 1996;56:4983–91.

    CAS  PubMed  Google Scholar 

  • Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, Caron MG, Lefkowitz RJ. Beta-arrestin- dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science. 1999;283:655–61.

    Article  CAS  PubMed  Google Scholar 

  • Malbon CC. G proteins in development. Nat Rev Mol Cell Biol. 2005;6:689–701.

    Article  CAS  PubMed  Google Scholar 

  • Medrano S, Gruenstein E, Dimlich RV. Substance P receptors on human astrocytoma cells are linked to glycogen breakdown. Neurosci Lett. 1994;167:14–8.

    Article  CAS  PubMed  Google Scholar 

  • Meshki J, Douglas SD, Lai JP, Schwartz L, Kilpatrick LE, Tuluc F. Neurokinin 1 receptor mediates membrane blebbing in HEK293 cells through a Rho/Rho- associated coiled-coil kinase-dependent mechanism. J Biol Chem. 2009;284:9280–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Meshki J, Douglas SD, Hu M, Leeman SE, Tuluc F. Substance P induces rapid and transient membrane blebbing in U373MG cells in a p21-activated kinase-dependent manner. PLoS One. 2011;6:e25332.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Muñoz M, Coveñas R. Involvement of substance P and the NK-1 receptor in cancer progression. Peptides. 2013;48:1–9.

    Article  CAS  PubMed  Google Scholar 

  • Muñoz M, Coveñas R. Involvement of substance P and NK-1 receptor in human pathology. Amino Acids. 2014;46:1727–50.

    Article  CAS  PubMed  Google Scholar 

  • Muñoz M, Pavón A, Rosso M, Pérez A, Salinas-Martín MV, Carranza A, González A. Immunolocalization of NK-1 receptor and substance P in human normal placenta. Placenta. 2010;31:649–51.

    Article  CAS  PubMed  Google Scholar 

  • Nakajima Y, Tsuchida K, Negishi M, Ito S, Nakanishi S. Direct linkage of three tachykinin receptors to stimulation of both phosphatidylinositol hydrolysis and cyclic AMP cascades in transfected Chinese hamster ovary cells. J Biol Chem. 1992;267:2437–42.

    CAS  PubMed  Google Scholar 

  • Neer EJ. G proteins: critical control points for transmembrane signals. Protein Sci. 1994;3:3–14.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Nishimura K, Frederick J, Kwatra MM. Human substance P receptor expressed in Sf9 cells couples with multiple endogenous G proteins. J Recept Signal Transduct Res. 1998;18:51–65.

    Article  CAS  PubMed  Google Scholar 

  • O’Connor TM, O’Connell J, O’Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol. 2004;201:167–80.

    Article  CAS  PubMed  Google Scholar 

  • Pennefather JN, Lecci A, Candenas ML, Patak E, Pinto FM, Maggi CA. Tachykinins and tachykinin receptors: a growing family. Life Sci. 2004;74:1445–63.

    Article  CAS  PubMed  Google Scholar 

  • Robinson P, Garza A, Moore J, Eckols TK, Parti S, Balaji V, Vallejo J, Tweardy DJ. Substance P is required for the pathogenesis of EMCV infection in mice. Int J Clin Exp Med. 2009;2:76–86.

    PubMed  PubMed Central  CAS  Google Scholar 

  • Ständer S, Siepmann D, Herrgott I, Sunderkötter C, Luger TA. Targeting the neurokinin receptor 1 with aprepitant: a novel antipruritic strategy. PLoS One. 2010;5:e10968.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Takeda Y, Chou KB, Takeda J, Sachais BS, Krause JE. Molecular cloning, structural characterization and functional expression of the human substance P receptor. Biochem Biophys Res Commun. 1991;179:1232–40.

    Article  CAS  PubMed  Google Scholar 

  • Theoharides TC, Zhang B, Kempuraj D, Tagen M, Vasiadi M, Angelidou A, Alysandratos KD, Kalogeromitros D, Asadi S, Stavrianeas N, Peterson E, Leeman S, Conti P. IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A. 2010;107:4448–53.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wang X, Douglas SD, Lai JP, Tuluc F, Tebas P, Ho WZ. Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro. J NeuroImmune Pharmacol. 2007;2:42–8.

    Article  PubMed  Google Scholar 

  • Ziche M, Morbidelli L, Pacini M, Gepetti P, Alessandri G, Maggi CA. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res. 1990;40:264–78.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Mr. Javier Muñoz (University of Seville, Spain) for technical assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Miguel Muñoz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Muñoz, M., Rosso, M., Coveñas, R. (2018). Neurokinin-1 Receptor. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_101781

Download citation

Publish with us

Policies and ethics